Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4466250
Max Phase: Preclinical
Molecular Formula: C41H42N10O8
Molecular Weight: 802.85
Molecule Type: Unknown
Associated Items:
ID: ALA4466250
Max Phase: Preclinical
Molecular Formula: C41H42N10O8
Molecular Weight: 802.85
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cccnc1)NC(=O)[C@@H]1CCCN1C(=O)N(Cc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)NC(=O)Cc1ccccc1
Standard InChI: InChI=1S/C41H42N10O8/c52-37(23-29-11-5-2-6-12-29)46-50(27-32-26-49(47-45-32)33-15-17-34(18-16-33)51(58)59)41(57)48-20-8-14-36(48)40(56)44-35(22-30-13-7-19-42-25-30)39(55)43-31(24-38(53)54)21-28-9-3-1-4-10-28/h1-7,9-13,15-19,25-26,31,35-36H,8,14,20-24,27H2,(H,43,55)(H,44,56)(H,46,52)(H,53,54)/t31-,35-,36-/m0/s1
Standard InChI Key: CGBMTHTTYSOKRY-AENKNVQRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 802.85 | Molecular Weight (Monoisotopic): 802.3187 | AlogP: 3.16 | #Rotatable Bonds: 16 |
Polar Surface Area: 234.89 | Molecular Species: ACID | HBA: 11 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.07 | CX Basic pKa: 4.98 | CX LogP: 2.33 | CX LogD: 0.19 |
Aromatic Rings: 5 | Heavy Atoms: 59 | QED Weighted: 0.08 | Np Likeness Score: -0.97 |
1. Mir FM, Atmuri NDP, Bourguet CB, Fores JR, Hou X, Chemtob S, Lubell WD.. (2019) Paired Utility of Aza-Amino Acyl Proline and Indolizidinone Amino Acid Residues for Peptide Mimicry: Conception of Prostaglandin F2α Receptor Allosteric Modulators That Delay Preterm Birth., 62 (9): [PMID:30932486] [10.1021/acs.jmedchem.9b00056] |
Source(1):